KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) Shares Outstanding (Weighted Average) (2016 - 2025)

CareDx's Shares Outstanding (Weighted Average) history spans 12 years, with the latest figure at $53.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 0.97% year-over-year to $53.3 million; the TTM value through Dec 2025 reached $53.3 million, up 0.97%, while the annual FY2025 figure was $53.3 million, 0.97% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $53.3 million at CareDx, down from $54.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $55.3 million in Q1 2025 and bottomed at $51.2 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $53.3 million (2022), against an average of $53.0 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) grew 19.52% in 2021 before it decreased 3.64% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $52.2 million in 2021, then increased by 2.07% to $53.3 million in 2022, then rose by 0.83% to $53.8 million in 2023, then decreased by 1.84% to $52.8 million in 2024, then increased by 0.97% to $53.3 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Shares Outstanding (Weighted Average) are $53.3 million (Q4 2025), $54.0 million (Q3 2025), and $54.3 million (Q2 2025).